Get access

Treatment of Lymphangioma Circumscriptum Using Fractional Carbon Dioxide Laser Ablation

Authors

Errata

This article is corrected by:

  1. Errata: Erratum Volume 32, Issue 5, 777, Article first published online: 10 September 2015

  • The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. government.

Address correspondence to Peter R. Shumaker, M.D., Department of Dermatology, Naval Medical Center, 34520 Bob Wilson Dr., Suite 300, San Diego, CA 92134, or e-mail: peter.shumaker@med.navy.mil.

Abstract

Lymphangioma circumscriptum remains a challenging entity to treat given anatomic considerations and a significant tendency for recurrence regardless of the modality selected. Surgical excision offers the greatest potential for definitive management but is often beset by procedural morbidity and suboptimal cosmetic outcomes. A range of palliative options have been reported for the treatment of lymphangioma circumscriptum, with varying degrees of associated efficacy and morbidity. This report describes the novel use of fractional carbon dioxide laser ablation for the treatment of lymphangioma circumscriptum, with promising cosmetic results and durable symptomatic relief.

Get access to the full text of this article

Ancillary